Valnemulin hydrochloride is an animal-specific antibiotic

Animal safety seriously affects human health. Especially in recent years, various animal diseases such as avian flu, swine flu, and mad cow disease foot-and-mouth disease have emerged in the world, which poses a great threat to human health. However, the use of common antibiotics can easily lead to animal diseases. The pathogens produce drug resistance, high drug residues and high toxicity, and have the disadvantages of teratogenic carcinogenic environment pollution. Therefore, the development of a good antibiotic has become a major trend in the development of veterinary drugs in the world today.
Valnemulin hydrochloride is a new generation of truncated Pleurotus semi-synthetic animal-specific antibiotics, which are diterpenes and are similar to tiamulin. It is mainly used for the prevention and treatment of mycoplasma and Gram-positive bacteria infection in pigs, cattle, sheep and poultry. It has the characteristics of broad spectrum, strong antibacterial activity, excellent pharmacokinetic characteristics, low residue and safety. Approved by the European Community in 1999 for the prevention and treatment of swine dysentery caused by B. hyodysenteriae infection and endemic pneumonia caused by Mycoplasma pneumoniae infection. In January 2004, the European Community approved the prevention of porcine colospirosis caused by infection with B. pilosicoli and the treatment of porcine proliferative enteropathy caused by infection with Lawsonia intracellularis.
Valnemulin hydrochloride is a chronic respiratory disease in chickens, endemic pneumonia in pigs (or swine asthma, mycoplasma pneumonia), actinomyctic pleuropneumonia, swine dysentery, porcine colonic spirochete (colitis), porcine proliferative enteropathy A very sensitive new animal-specific antibiotic for diseases such as ileitis, which has broad application prospects.